[Special Stock] NanoEntek, COVID-19 On-Site Diagnosis Within 3 Minutes... Also Approved for Flu Diagnostic Kit

[Asia Economy Reporter Park Hyungsoo] NanoEntek is showing strong performance. Expectations for its novel coronavirus disease (COVID-19) diagnostic business appear to be influencing its stock price.

As of 9:42 AM on the 11th, NanoEntek is trading at 14,850 KRW, up 7.61% from the previous day.

On this day, NanoEntek announced that it received usage approval from Brazil's National Health Surveillance Agency (ANVISA) for its COVID-19 antibody diagnostic kit (FREND COVID-19 IgG/IgM Duo).

Previously, NanoEntek obtained export approval from the Korean Ministry of Food and Drug Safety for its COVID-19 diagnostic kit (FREND COVID-19 SP), which detects antibodies against the spike protein of the COVID-19 virus.

Recently, antibodies against the spike protein have been known to neutralize the COVID-19 virus, and vaccine development utilizing this is actively underway. Therefore, detecting antibodies against this spike protein can not only diagnose COVID-19 infection but also evaluate the effectiveness of vaccines by determining whether the body has properly produced antibodies after vaccination.

NanoEntek's FREND point-of-care diagnostic system, which includes the COVID-19 diagnostic kits, uses an advanced lab-on-a-chip platform that integrates semiconductor design technology (MEMS) with biotechnology, enabling testing within 3 minutes.

In the case of pandemic diseases, managing a vast amount of patient results is very important. NanoEntek's FREND is equipped with a Laboratory Information System (LIS) function, which automatically transmits results, allowing effective management of patient information without omissions.

In August, NanoEntek already received approval from the Ministry of Food and Drug Safety for domestic and overseas sales of FREND FLU A&B, a fluorescent immunoassay-based influenza diagnostic kit. Currently, both influenza and COVID-19 tests can be easily and conveniently conducted using the FREND System.

Regarding infectious disease diagnostics, NanoEntek has completed export approvals for three types of COVID-19 antibody kits (COVID-19 NC/SP/Ab) and COVID-19 molecular diagnostic kits (PCR). The influenza diagnostic kit (FLU A&B) is approved for both export and domestic sales. Additionally, NanoEntek has completed development of an antigen diagnostic kit (COVID-19 Ag) capable of early COVID-19 infection detection and is in the process of obtaining export approval, actively responding to increasingly threatening infectious diseases as winter approaches.

This content was produced with the assistance of AI translation services.